Cargando…

Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study

Age is a known predictor of blood pressure (BP); however, the literature mostly includes cross‐sectional investigations. This prospective cohort study aimed to decompose the cross‐sectional and longitudinal age effects on BP. The secondary data were obtained from the Tehran lipid and glucose study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Khajavi, Alireza, Zayeri, Farid, Ramezankhani, Azra, Nazari, Amir, Azizi, Fereidoun, Hadaegh, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678670/
https://www.ncbi.nlm.nih.gov/pubmed/33720477
http://dx.doi.org/10.1111/jch.14238
_version_ 1784616356053778432
author Khajavi, Alireza
Zayeri, Farid
Ramezankhani, Azra
Nazari, Amir
Azizi, Fereidoun
Hadaegh, Farzad
author_facet Khajavi, Alireza
Zayeri, Farid
Ramezankhani, Azra
Nazari, Amir
Azizi, Fereidoun
Hadaegh, Farzad
author_sort Khajavi, Alireza
collection PubMed
description Age is a known predictor of blood pressure (BP); however, the literature mostly includes cross‐sectional investigations. This prospective cohort study aimed to decompose the cross‐sectional and longitudinal age effects on BP. The secondary data were obtained from the Tehran lipid and glucose study, which comprised six repeated measurements of participants, with median follow‐up of 15.8 (interquartile range of 14.2‐16.9) years. The sample is representative of the metropolitan area of Tehran, Iran, containing 7,460 participants aged 20‐70. The cross‐sectional and longitudinal effects of age (age at baseline and aging, respectively) were fitted in the mixed effects models, taking systolic, diastolic, and pulse BPs as response, adjusting for adiposity, smoking, diabetes, and antihypertensive medication, and stratifying for sex and 10‐year age‐groups. The mean age at baseline was 41.3 (SD = 12.9) years, and 41.7% of the participants were male. Age at baseline and aging were directly associated with BP, aging owned the weaker effect, and the largest distinction were for systolic blood pressure of men aged 40‐49 years (0.75 vs 0.10, p‐value < .001). Moreover, the aging effects on systolic and diastolic BPs were higher in men than women, in the age groups 40‐49 and 30‐39 years (0.35 vs 0.10 and 0.30 vs 0.07, p‐values < .001), respectively. Adjusting for adiposity remarkably declined the impact of aging on BP, among the < 50 years old.
format Online
Article
Text
id pubmed-8678670
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86786702021-12-23 Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study Khajavi, Alireza Zayeri, Farid Ramezankhani, Azra Nazari, Amir Azizi, Fereidoun Hadaegh, Farzad J Clin Hypertens (Greenwich) Aging Age is a known predictor of blood pressure (BP); however, the literature mostly includes cross‐sectional investigations. This prospective cohort study aimed to decompose the cross‐sectional and longitudinal age effects on BP. The secondary data were obtained from the Tehran lipid and glucose study, which comprised six repeated measurements of participants, with median follow‐up of 15.8 (interquartile range of 14.2‐16.9) years. The sample is representative of the metropolitan area of Tehran, Iran, containing 7,460 participants aged 20‐70. The cross‐sectional and longitudinal effects of age (age at baseline and aging, respectively) were fitted in the mixed effects models, taking systolic, diastolic, and pulse BPs as response, adjusting for adiposity, smoking, diabetes, and antihypertensive medication, and stratifying for sex and 10‐year age‐groups. The mean age at baseline was 41.3 (SD = 12.9) years, and 41.7% of the participants were male. Age at baseline and aging were directly associated with BP, aging owned the weaker effect, and the largest distinction were for systolic blood pressure of men aged 40‐49 years (0.75 vs 0.10, p‐value < .001). Moreover, the aging effects on systolic and diastolic BPs were higher in men than women, in the age groups 40‐49 and 30‐39 years (0.35 vs 0.10 and 0.30 vs 0.07, p‐values < .001), respectively. Adjusting for adiposity remarkably declined the impact of aging on BP, among the < 50 years old. John Wiley and Sons Inc. 2021-03-15 /pmc/articles/PMC8678670/ /pubmed/33720477 http://dx.doi.org/10.1111/jch.14238 Text en © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Aging
Khajavi, Alireza
Zayeri, Farid
Ramezankhani, Azra
Nazari, Amir
Azizi, Fereidoun
Hadaegh, Farzad
Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
title Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
title_full Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
title_fullStr Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
title_full_unstemmed Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
title_short Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
title_sort age and aging effects on blood pressure: 15 years follow‐up of tehran lipid and glucose study
topic Aging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678670/
https://www.ncbi.nlm.nih.gov/pubmed/33720477
http://dx.doi.org/10.1111/jch.14238
work_keys_str_mv AT khajavialireza ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy
AT zayerifarid ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy
AT ramezankhaniazra ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy
AT nazariamir ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy
AT azizifereidoun ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy
AT hadaeghfarzad ageandagingeffectsonbloodpressure15yearsfollowupoftehranlipidandglucosestudy